Patients accept therapy using embryonic stem cells for Parkinson ’s disease: a discrete choice experiment
New disease-modifying ways to treat Parkinson ’s disease (PD) may soon become a reality with intracerebral transplantation of cell products produced from human embryonic stem cells (hESCs). The aim of this stud...
Source: BMC Medical Ethics - Category: Medical Ethics Authors: Karin Sch ölin Bywall, Jennifer Drevin, Catharina Groothuis-Oudshoorn, Jorien Veldwijk, Dag Nyholm, Hakan Widner, Trinette van Vliet, Elena Jiltsova, Mats Hansson and Jennifer Viberg Johansson Tags: Research Source Type: research